Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing
OBJECTIVE: To characterize the population pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis (ABECB), with particular attention to the speed of bacterial killing. This was possible because the study design incorporated dai...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
1998-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1998/407350 |
id |
doaj-0a5113e2609445b39c77f0d82122f7f0 |
---|---|
record_format |
Article |
spelling |
doaj-0a5113e2609445b39c77f0d82122f7f02020-11-24T23:59:39ZengHindawi LimitedCanadian Journal of Infectious Diseases1180-23321998-01-019Suppl E16E22E10.1155/1998/407350Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial KillingJerome J Schentag0SUNY, Buffalo Clinical Pharmacokinetics Laboratory, Millard Fillmore Health System, Buffalo, New York, USAOBJECTIVE: To characterize the population pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis (ABECB), with particular attention to the speed of bacterial killing. This was possible because the study design incorporated daily cultures of the patients’ sputum.http://dx.doi.org/10.1155/1998/407350 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jerome J Schentag |
spellingShingle |
Jerome J Schentag Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing Canadian Journal of Infectious Diseases |
author_facet |
Jerome J Schentag |
author_sort |
Jerome J Schentag |
title |
Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing |
title_short |
Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing |
title_full |
Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing |
title_fullStr |
Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing |
title_full_unstemmed |
Grepafloxacin in Patients with Acute Bacterial Exacerbations of Chronic Bronchitis - a Question of Speed in Bacterial Killing |
title_sort |
grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis - a question of speed in bacterial killing |
publisher |
Hindawi Limited |
series |
Canadian Journal of Infectious Diseases |
issn |
1180-2332 |
publishDate |
1998-01-01 |
description |
OBJECTIVE: To characterize the population pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis (ABECB), with particular attention to the speed of bacterial killing. This was possible because the study design incorporated daily cultures of the patients’ sputum. |
url |
http://dx.doi.org/10.1155/1998/407350 |
work_keys_str_mv |
AT jeromejschentag grepafloxacininpatientswithacutebacterialexacerbationsofchronicbronchitisaquestionofspeedinbacterialkilling |
_version_ |
1725446867590840320 |